Dave Rosa
2021
In 2021, Dave Rosa earned a total compensation of $1.9M as Chief Executive Officer and President at NEUROONE MEDICAL TECHNOLOGIES Corp, a 67% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $192,608 |
|---|---|
| Option Awards | $1,285,899 |
| Salary | $410,844 |
| Total | $1,889,351 |
Rosa received $1.3M in option awards, accounting for 68% of the total pay in 2021.
Rosa also received $192.6K in non-equity incentive plan and $410.8K in salary.
Rankings
In 2021, Dave Rosa's compensation ranked 6,259th out of 12,405 executives tracked by ExecPay. In other words, Rosa earned more than 49.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,259 out of 12,405 | 50th |
Division Manufacturing | 2,658 out of 5,494 | 52nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 336 out of 798 | 58th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 208 out of 519 | 60th |
Industry Surgical and Medical Instruments and Apparatus | 134 out of 324 | 59th |
Source: SEC filing on April 29, 2022.
Rosa's colleagues
We found two more compensation records of executives who worked with Dave Rosa at NEUROONE MEDICAL TECHNOLOGIES Corp in 2021.
News
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2023 pay slips 17% to $990K
January 29, 2024
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2022 pay falls 37% to $1.2M
January 27, 2023
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2021 pay jumps 67% to $1.9M
April 29, 2022
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2020 pay jumps 103% to $1.1M
May 6, 2021